Life Sciences
We assisted eResearch (NASDAQ: ERES) in its acquisition of the Cardiac Safety Services business unit of Covance, Inc. (NYSE: CRO).
We advised Exygen Research, Inc. in an exclusive sale transaction.
Advised Corcell, Inc. and rendered a fairness opinion in connection with its merger with Vita 34, AG.
Provided valuation analysis to Galenea Corp. in connection with its first round of financing and a collaboration agreement with Otsuka Pharmaceuticals of Japan.
We assisted Noble Biomaterials, Inc. in raising $13 million in private equity from TL Ventures and DuPont Capital Management.
Conducted a strategic alternatives review and advised TissueInformatics, Inc. in connection with its merger with Paradigm Genetics, Inc. (NASDAQ:PDGM).
We provided valuation analyses to Decision Biomarkers, Metacure, and Seahorse Bioscience in connection with issuing stock options.
Healthcare Services
We provided board advisory services to AllHealth in connection with its sale to Amerinet Central.
Advised Wasserott's Inc. in its sale to Apria Healthcare (NYSE:AHG).
We assisted Sunbury Community Hospital in evaluating a purchase proposal.
Assisted WorldWide
Medical Corp. (NASDAQ:WMED) in the sale of its assets under
Sec 363 of the U.S. Bankruptcy Code.
